SRX Global Inc. SRXH
0.91 USD -0.06 (-5.72%)
Nov 3, 2026, 3:17 PM EST
0.8697 Day range 0.9915
0.85 52-week range 42.60
- YTD
- -93.32%
- 1 year
- -95.02%
- Market cap
- 18.45M
- EPS (ttm)
- 59.72
- Shares out
- 858.60M
- P/E ratio
- 0.02
- YTD return
- -93.32%
- 1-year return
- -95.02%
- Volume
- 300.56K
- Avg volume
- 729.68K
- Open
- 0.9773
- Previous close
- 0.9698
- Day's range
- 0.8697 – 0.9915
- 52-week range
- 0.85 – 42.60
2Y -93.3184 (-99.04%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 36.79
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.06%
- 50-day average
- 7.12
- 200-day average
- 12.23
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
SRXH Revenue — quarterly 3.39M
SRXH Net income — quarterly -4.14M
SRXH EPS — quarterly -0.36
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 14, 2026 | Mar 31, 2026 | -0.26 | -1.20 | -0.94 | -361.54% |
| Feb 13, 2026 | Dec 31, 2025 | — | -0.17 | — | — |
| Nov 10, 2025 | Sep 30, 2025 | — | -24.00 | — | — |
| Sep 30, 2025 | Jun 30, 2025 | -4.84 | -0.74 | +4.10 | +84.71% |
| May 15, 2025 | Mar 31, 2025 | -2.21 | -0.37 | +1.84 | +83.26% |
| Mar 27, 2025 | Dec 31, 2024 | -2.20 | -30.00 | -27.80 | -1,264.55% |
About SRX Global Inc.
SRX Global Inc. designs and develops an artificial intelligence (AI)-based platform to enhance decision making, operations, and risk management. The company is based in Tampa, Florida.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Country
- United States
- Website
- srxglobalinc.com
News
SRX Global Says As Of October 30, 2026, The Company Has ~$34M In Aggregate Cash, Cash Equivalents, Restricted Cash And Short-Term U.S. Treasury Bills; The Company Does Not Have Any Exposure To Cryptocurrency As Of Today 
SRX Global Provides Update on Balance Sheet and Share Buyback 
SRX Global Says UC Davis Activated As Clinical Trial Site For CERTAIN-T, Ongoing Phase 1 Study Evaluating CER-1236 In Patients With Hematologic Malignancies Being Conducted By CERo Therapeutics 
SRX Global Announces Activation of the University of California, Davis as a Clinical Trial Site for CERo Therapeutics' Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies 
SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform 
SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies 
SRX Global Announces $1.5M Commitment To Roll Out New Family Of Actively Managed ETFs 
SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim 
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO) 
SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
Your note
Sign in to keep a note on SRXH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CONACHER LIONEL F | Director | Sale | Dec 22, 2024 | 36,597 |
| CONWAY SIMON ALEXANDER MALCOLM | Director | Stock Award(Grant) | Dec 2, 2025 | 1,039,580 |
| CUNNINGHAM KENT | Chief Executive Officer | Stock Award(Grant) | Dec 2, 2025 | 0 |
| WHITE DAVID ALLAN | Director | Stock Award(Grant) | Aug 24, 2025 | 731,406 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Jane Street Group, LLC | 0.00% | 9,921 | 13.51K | Mar 30, 2026 |
| Geode Capital Management, LLC | 0.00% | 4,125 | 5.62K | Mar 30, 2026 |
| Two Sigma Securities, LLC | 0.00% | 3,254 | 4.43K | Mar 30, 2026 |
| Scotia Capital Inc. | 0.00% | 1,802 | 2.45K | Mar 30, 2026 |
| UBS Group AG | 0.00% | 1,429 | 1.95K | Mar 30, 2026 |
| Xtx Topco Ltd | 0.00% | 1,222 | 1.66K | Mar 30, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 0.00% | 3,828 | 5.21K | May 30, 2026 |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 0.00% | 195 | 265 | May 30, 2026 |